Literature DB >> 29560693

Apoptosis and Disease Severity is Associated with Insulin Resistance in Non-alcoholic Fatty Liver Disease.

Kadri Atay1, Billur Canbakan1, Emine Koroglu2, Ibrahim Hatemi1, Mustafa Canbakan3, Nuray Kepil4, Murat Tuncer1, Hakan Senturk5.   

Abstract

BACKGROUNDS AND AIMS: Non-alcoholic fatty liver disease (NAFLD) is associated with insulin resistance (IR). We evaluated whether IR contributes to hepatocyte apoptosis, inflammation, and fibrosis in NAFLD.
METHODS: Forty-four teetotaller patients with biopsy-proven diagnosis of NAFLD were enrolled. Twenty-eight NAFLD patients with IR were compared with 16 subjects without IR. For apoptotic activity caspase 3 and 8, transcription nuclear factor kB (NF-kB), and anti-apoptotic Bcl-2 protein were determined through immunohistochemical methods.
RESULTS: HOMA-IR index was significantly correlated with the stage and caspase 3- and 8 levels (p= 0.001, 0.02, and 0.01, respectively). HOMA-IR index was independently associated with the severity of fibrosis ( = 5.9, p = 0.001), caspase-3 ( = 0.16, p = 0.001), and caspase-8 (b =0.032, p = 0.018) levels. TNF-sRp55 level was positively correlated with HOMA-IR index (p = 0.024). Patients with IR had significantly higher necroinflammatory grade, stage, caspase-3, and caspase-8 levels than those without IR (p = 0.022, 0.007, 0.031, and p = 0.011, respectively). HOMA-IR index had statistically significant values for distinguishing of severe necroinflammatory grade, stage and for differentiating NASH from simple fatty liver (AUC = 0.78, 0.76, and 0.82, respectively).
CONCLUSION: This study demonstrates that IR in NAFLD is associated with enhanced hepatocyte apoptosis and histopathologic disease severity. These data indicate that NAFLD patients with IR may have increased risk for disease progression. © Acta Gastro-Enterologica Belgica.

Entities:  

Keywords:  apoptosis; fatty liver disease; insulin resistance

Mesh:

Substances:

Year:  2017        PMID: 29560693

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  2 in total

1.  The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect.

Authors:  Kira Derkach; Irina Zakharova; Inna Zorina; Andrey Bakhtyukov; Irina Romanova; Liubov Bayunova; Alexander Shpakov
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

Review 2.  A Potential Linking between Vitamin D and Adipose Metabolic Disorders.

Authors:  Zhiguo Miao; Shan Wang; Yimin Wang; Liping Guo; Jinzhou Zhang; Yang Liu; Qiyuan Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2020-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.